BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bykov I, Junnikkala S, Pekna M, Lindros KO, Meri S. Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver. Clin Immunol. 2007;124:213-220. [PMID: 17586095 DOI: 10.1016/j.clim.2007.05.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Naponelli V, Bettuzzi S. Clusterin. The Complement FactsBook. Elsevier; 2018. pp. 341-9. [DOI: 10.1016/b978-0-12-810420-0.00032-8] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Kaliappan S, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS. Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system. FEBS Lett 2008;582:3451-8. [PMID: 18789935 DOI: 10.1016/j.febslet.2008.09.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
3 Chan C, Levitsky J. Infection and Alcoholic Liver Disease. Clin Liver Dis 2016;20:595-606. [PMID: 27373619 DOI: 10.1016/j.cld.2016.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
4 Santiesteban-Lores LE, Carneiro MC, Isaac L, Bavia L. Complement System in Alcohol-Associated Liver Disease. Immunol Lett 2021;236:37-50. [PMID: 34111475 DOI: 10.1016/j.imlet.2021.05.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peixoto E, Atorrasagasti C, Aquino JB, Militello R, Bayo J, Fiore E, Piccioni F, Salvatierra E, Alaniz L, García MG. SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage. Gene Ther. 2015;22:9-19. [PMID: 25410742 DOI: 10.1038/gt.2014.102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Asimakopoulou A, Fülöp A, Borkham-Kamphorst E, de Leur EV, Gassler N, Berger T, Beine B, Meyer HE, Mak TW, Hopf C, Henkel C, Weiskirchen R. Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis. Biochim Biophys Acta Mol Basis Dis 2017;1863:2093-110. [PMID: 28396286 DOI: 10.1016/j.bbadis.2017.04.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
7 Dekens DW, Eisel ULM, Gouweleeuw L, Schoemaker RG, De Deyn PP, Naudé PJW. Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases. Ageing Res Rev 2021;70:101414. [PMID: 34325073 DOI: 10.1016/j.arr.2021.101414] [Reference Citation Analysis]
8 Adler M, Hoffmann D, Ellinger-Ziegelbauer H, Hewitt P, Matheis K, Mulrane L, Gallagher WM, Callanan JJ, Suter L, Fountoulakis MM, Dekant W, Mally A. Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studies. Toxicol Lett 2010;196:1-11. [PMID: 20362651 DOI: 10.1016/j.toxlet.2010.03.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
9 Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD. Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study. Eur J Clin Invest. 2013;43:679-688. [PMID: 23586841 DOI: 10.1111/eci.12093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
10 Kaphalia L, Calhoun WJ. Alcoholic lung injury: metabolic, biochemical and immunological aspects. Toxicol Lett 2013;222:171-9. [PMID: 23892124 DOI: 10.1016/j.toxlet.2013.07.016] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 6.2] [Reference Citation Analysis]
11 Asimakopoulou A, Weiskirchen R. Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis. Clinical Lipidology 2015;10:47-67. [DOI: 10.2217/clp.14.65] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 2012;1826:129-169. [PMID: 22513004 DOI: 10.1016/j.bbcan.2012.03.008] [Cited by in Crossref: 124] [Cited by in F6Publishing: 208] [Article Influence: 12.4] [Reference Citation Analysis]
13 Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Semin Immunopathol 2008;30:85-95. [PMID: 18299835 DOI: 10.1007/s00281-008-0110-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
14 Zhang C, Li X, Jing X, Zhang B, Zhang Q, Niu Q, Wang J, Tian Z. Protective effects of oyster extract against hepatic tissue injury in alcoholic liver diseases. J Ocean Univ China 2014;13:262-70. [DOI: 10.1007/s11802-014-2449-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mellbin LG, Bjerre M, Thiel S, Hansen TK. Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 2012;35:911-7. [PMID: 22357179 DOI: 10.2337/dc11-1642] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
16 Gyamfi MA, Wan YJ. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp Biol Med (Maywood). 2010;235:547-560. [PMID: 20463294 DOI: 10.1258/ebm.2009.009249] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
17 Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 2009;50:1521-37. [PMID: 19001666 DOI: 10.1194/jlr.M800418-JLR200] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
18 Alwahsh SM, Xu M, Schultze FC, Wilting J, Mihm S, Raddatz D, Ramadori G. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS One 2014;9:e104220. [PMID: 25101998 DOI: 10.1371/journal.pone.0104220] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
19 Glavind E, Vilstrup H, Grønbaek H, Hamilton-Dutoit S, Magnusson NE, Thomsen KL. Long-Term Ethanol Exposure Decreases the Endotoxin-Induced Hepatic Acute Phase Response in Rats. Alcohol Clin Exp Res 2017;41:562-70. [PMID: 28055129 DOI: 10.1111/acer.13328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Masuo Y, Imai T, Shibato J, Hirano M, Jones OA, Maguire ML, Satoh K, Kikuchi S, Rakwal R. Omic analyses unravels global molecular changes in the brain and liver of a rat model for chronic Sake (Japanese alcoholic beverage) intake. Electrophoresis 2009;30:1259-75. [PMID: 19382137 DOI: 10.1002/elps.200900045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
21 McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE. Complement Factor D protects mice from ethanol-induced inflammation and liver injury. Am J Physiol Gastrointest Liver Physiol. 2018;315:G66-G79. [PMID: 29597356 DOI: 10.1152/ajpgi.00334.2017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
22 Daigo K, Inforzato A, Barajon I, Garlanda C, Bottazzi B, Meri S, Mantovani A. Pentraxins in the activation and regulation of innate immunity. Immunol Rev 2016;274:202-17. [PMID: 27782337 DOI: 10.1111/imr.12476] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
23 Bavia L, de Castro ÍA, Cogliati B, Dettoni JB, Alves VAF, Isaac L. Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background. Immunobiology 2016;221:822-32. [DOI: 10.1016/j.imbio.2016.01.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
24 Zhou DX, Zhao Y, Baker JA, Gu Q, Hamre KM, Yue J, Jones BC, Cook MN, Lu L. The effect of alcohol on the differential expression of cluster of differentiation 14 gene, associated pathways, and genetic network. PLoS One 2017;12:e0178689. [PMID: 28575045 DOI: 10.1371/journal.pone.0178689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Hu M, Yin H, Mitra MS, Liang X, Ajmo JM, Nadra K, Chrast R, Finck BN, You M. Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice. Hepatology 2013;58:1953-63. [PMID: 23787969 DOI: 10.1002/hep.26589] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
26 Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
27 Khandhadia S, Hakobyan S, Heng LZ, Gibson J, Adams DH, Alexander GJ, Gibson JM, Martin KR, Menon G, Nash K, Sivaprasad S, Ennis S, Cree AJ, Morgan BP, Lotery AJ. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation. Ophthalmology 2013;120:1612-8. [PMID: 23562165 DOI: 10.1016/j.ophtha.2013.01.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
28 Falgarone G, Chiocchia G. Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 2009;104:139-70. [PMID: 19878776 DOI: 10.1016/S0065-230X(09)04008-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
29 Spadaro G, D'Orio C, Genovese A, Galeotafiore A, D'Ambrosio C, Di Giovanni S, Vitale M, Capasso M, Lamberti V, Scaloni A, Marone G, Zambrano N. Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy. J Biomed Biotechnol 2011;2011:706746. [PMID: 21960740 DOI: 10.1155/2011/706746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
30 Lung T, Sakem B, Risch L, Würzner R, Colucci G, Cerny A, Nydegger U. The complement system in liver diseases: Evidence-based approach and therapeutic options. J Transl Autoimmun 2019;2:100017. [PMID: 32743505 DOI: 10.1016/j.jtauto.2019.100017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
31 Hsieh PS. Inflammatory change of fatty liver induced by intraportal low-dose lipopolysaccharide infusion deteriorates pancreatic insulin secretion in fructose-induced insulin-resistant rats. Liver Int. 2008;28:1167-1175. [PMID: 18397237 DOI: 10.1111/j.1478-3231.2008.01714.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
32 Xu MJ, Zhou Z, Parker R, Gao B. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther 2017;180:77-89. [PMID: 28642119 DOI: 10.1016/j.pharmthera.2017.06.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]